Cardiology

Back to articles

New cholesterol guideline: LDL goals take backseat to statins

KEY POINT

The American College of Cardiology and the American Heart Association (ACC/AHA) have jointly issued a new guideline for cholesterol management. Based on a systematic evidence review, an expert panel found no evidence supporting use of fixed LDL cholesterol (LDL–C) or non-HDL cholesterol (non-HDL–C) goals to guide therapy. Instead, the guideline identifies patient groups for whom moderate- or high-intensity statin therapy is recommended. This guideline—which replaces the Adult Treatment Panel III, better known as ATP III—should be used with updated AHA/ACC recommendations for cardiovascular risk assessment, lifestyle, and obesity management for atherosclerotic cardiovascular disease (ASCVD) prevention.

SOURCES

2013 ACC/AHA/TOS guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Released online in manuscript form by the Journal of the American College of Cardiology and Circulation; republished at JAPhA.